12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies
12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 20, 2016
Eden Roc Miami
4525 Collins Avenue
Miami Beach, FL 33140
The 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of melanoma and other cutaneous malignancies.
The field of skin cancer treatment remains one of the most rapidly evolving areas in oncology and has been a major focus of novel drug development. In particular, the advent of targeted and immunotherapeutic approaches to manage these malignancies has transformed care in recent years. There are also many investigational strategies in late-stage development, and these promise to further change practice in 2016. This is great news for patients, but also challenges busy clinicians to maintain state-of-the-art approaches in their practices.
This year’s program will focus on a number of core areas that are key to personalizing care for these tumors in contemporary practices settings, including sessions on immunotherapies, targeted therapies, regional therapy, and integrated medicine/patient care. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with skin cancer unique access to renowned international experts in the management of these tumors.
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
At the conclusion of this activity, participants should be better prepared to:
Choose treatment based on patient characteristics, such as age and performance status
Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients
Review strategies for mitigating and managing adverse events related to therapy
Describe current and emerging strategies for individualizing therapy
Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies
Jeffrey Weber, MD, PhD
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, NY
Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Director, Cutaneous Malignancies – The Angeles Clinic and Research Institute
Director of Experimental Therapeutics, Cedars Sinai Medical Care Foundation
Los Angeles, CA
Chair, Moffitt Board of Advisors
Miami Dolphins Radio Analyst
Member, College and Pro Football Halls of Fame